New Medicines, Novel Insights: Accelerating the new frontiers in neuroscience
Related Insights
Webinar
Incorporating the Patient Voice: How Patient Insights Drive Trial Design and Outcome Measures in Schizophrenia Research
Oct 30, 2024
Blog
Parkinson’s Disease Patient Advocacy Q&A
Sep 18, 2024
Webinar
Alzheimer’s Disease vs Multiple Sclerosis Drug Development: Similarities, Differences & New Perspectives
Aug 22, 2024
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
Deriving meaningful insights from real-world data for diverse Alzheimer’s research studies
Mar 19, 2024
Blog
Opportunities and strategies for accelerating patient access to treatments for Alzheimer’s disease
Feb 23, 2024
Blog
As more neuroscience drugs are approved, the value proposition takes center stage
Feb 14, 2024
Blog
How sponsors can make it easier for rare disease patients and families to participate in trials
Feb 13, 2024
Blog
How we can bring gene therapies to bear on diseases of aging
Jan 31, 2024
Blog
Improving and accelerating clinical research in dementia by integrating the patient’s voice throughout the development journey
Jan 24, 2024
Blog
Regulatory considerations in designing clinical trials for Alzheimer’s disease
Jan 24, 2024
Blog
Building a program for patient-guided clinical research for Alzheimer’s disease
Jan 24, 2024
Related Insights
Webinar
Incorporating the Patient Voice: How Patient Insights Drive Trial Design and Outcome Measures in Schizophrenia Research
Oct 30, 2024
Blog
Parkinson’s Disease Patient Advocacy Q&A
Sep 18, 2024
Webinar
Alzheimer’s Disease vs Multiple Sclerosis Drug Development: Similarities, Differences & New Perspectives
Aug 22, 2024
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
Deriving meaningful insights from real-world data for diverse Alzheimer’s research studies
Mar 19, 2024
Blog
Opportunities and strategies for accelerating patient access to treatments for Alzheimer’s disease
Feb 23, 2024
Blog
As more neuroscience drugs are approved, the value proposition takes center stage
Feb 14, 2024
Blog
How sponsors can make it easier for rare disease patients and families to participate in trials
Feb 13, 2024
Blog
How we can bring gene therapies to bear on diseases of aging
Jan 31, 2024
Blog
Improving and accelerating clinical research in dementia by integrating the patient’s voice throughout the development journey
Jan 24, 2024
Blog
Regulatory considerations in designing clinical trials for Alzheimer’s disease
Jan 24, 2024
Blog
Building a program for patient-guided clinical research for Alzheimer’s disease
Jan 24, 2024